A Prospective Study of Peritransplant Sorafenib for Patients with FLT3-ITD Acute Myeloid Leukemia Undergoing Allogeneic Transplantation

FLT3-ITD-mutated acute myeloid leukemia (AML) remains a therapeutic challenge. FLT3 inhibition in the setting of minimal residual disease and a new immune system via allogeneic transplantation offers a promise of improved survival for these patients. We performed a prospective study of patients with...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Biol Blood Marrow Transplant
Autori principali: Pratz, Keith W., Rudek, Michelle A., Smith, B. Douglas, Karp, Judith, Gojo, Ivana, Dezern, Amy, Jones, Richard J., Greer, Jackie, Gocke, Christopher, Baer, Maria R., Duong, Vu H., Rosner, Gary, Zahurak, Marianna, Wright, John J., Emadi, Ashkan, Levis, Mark
Natura: Artigo
Lingua:Inglês
Pubblicazione: 2019
Soggetti:
Article
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC7001148/
https://ncbi.nlm.nih.gov/pubmed/31550496
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.bbmt.2019.09.023
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi